CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS Today Blog.
 

Medicare takes a swing at radiation oncology; ASTRO swings back

By Greg Freiherr | September 4, 2009

Freestanding and community-based cancer centers will be leading with their chins if the Centers for Medicare and Medicaid Services revises its reimbursement rules on equipment utilization. The proposed rule would increase the utilization rate for radiation therapy equipment to 90% from the current level of 50%. While CMS projects the overall impact of the payment reductions to be 19%, the rates for certain needed cancer services would be reduced by up to 44%, according to the American Society for Radiation Oncology. ASTRO says the change, if it goes through, could cause many of these cancer centers to close, stop accepting Medicare patients, or reduce critical services.

CMS is not singling out radiation oncology. Far from it. The DC bureaucrats want to apply this rule to all owners of medical equipment costing more than $1 million. ASTRO and other groups who depend on such high-tech, big-ticket equipment, including medical imagers, are kicking up a storm about the proposal, labeling it as a roundabout way to reduce expenditures. By increasing the utilization rate, payments for services go way down, adding much needed dollars to a CMS budget that is coming under increasing financial pressure.

Last week ASTRO officially requested that CMS not adopt the proposed change. In its letter to CMS, the society took the opportunity to pick a couple other bones as well, contesting the way CMS calculates practice expenses; citing issues with the proposed changes in malpractice relative value units, as well as its plans to eliminate consultation codes; and calling for significant adjustments to the Physician Practice Information Survey data for radiation oncology. ASTRO gave CMS a detailed analysis showing that data for radiation oncology from the PPIS was improperly weighted and distorted.

"We believe we have identified several areas for CMS to explore as it finalizes the proposed rule for physician services. We hope the agency will consider these recommendations for the sake of the hundreds of thousands of cancer patients we serve each year," said Dr. Patricia Eifel, a radiation oncologist at M.D. Anderson Cancer Center in Houston and chairman of ASTRO.

Helping to convince CMS of the need for such deliberation are Reps. Lois Capps (D-CA), Sue Myrick (R-NC), Mike Rogers (R-MI), and Parker Griffith (D-AK) and 59 other members of the House of Representatives who sent a letter to Health and Human Services Secretary Kathleen Sebelius asking her to reconsider the proposed cuts. A similar letter is circulating in the Senate. Sens. Blanche Lincoln (D-AR) and Richard Burr (R-NC) are among 10 senators already committed to signing the letter.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by james florida | March 19, 2010 2:09 AM EDT


Patients undergoing florida radiation oncology for are treated with a linear accelerator, equipment that produces a radiation beam of either electrons or high energy X-rays. The beam is adjusted to match the patient's tumor shape.






 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 


 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Head and Neck Tumors
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter


CancerNetwork on Facebook

 


CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy